For athletes with diabetes, continuous glucose monitors are game-changers, helping them avoid dangerous blood sugar crashes ...

The global remote patient monitoring (RPM) market is estimated to be valued at $40 Billion in 2023, and is expected to grow ...

Continuous glucose monitors, or CGMs, are devices that track blood sugar in real-time and can tell wearers how their bodies ...

First author Boris Kovatchev said: “The landmark 10-year, 1,440-person Diabetes Control and Complications Trial (DCCT), ...

Glucose monitoring without piercing the skin is a prize companies like Apple and Samsung have been aiming for. Now, Samsung ...

Glucotrack (GCTK) reports successful completion of first human clinical study for continuous blood glucose monitoring, shares ...

This CGM will track your body's response - Could personalised glucose data inform your body’s metabolism and performance?

This study represents the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations ...

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

Detailed price information for Senseonics Holdings (SENS-A) from The Globe and Mail including charting and trades.

In a new study, researchers found that time-in-range for healthy blood sugar could be a viable marker of glycemic control and potentially could be used to predict complications of type 1 diabetes.